BioAtla Stock (NASDAQ: BCAB) stock price, news, charts, stock research, profile.
|Vol / Avg.630.602K / 349.781K||Mkt Cap84.846M|
|Day Range1.710 - 1.910||52 Wk Range1.240 - 11.710|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-11-08||HC Wainwright & Co.||Arthur He||Maintains||BuyBuy||Lowers||17.00||10.00|
|2023-09-25||JP Morgan||Brian Cheng||Maintains||OverweightOverweight||Lowers||17.00||14.00|
|2023-08-02||JP Morgan||Brian Cheng||Maintains||OverweightOverweight||Lowers||19.00||17.00|
|2023-08-02||JMP Securities||Reni Benjamin||Reiterates||Market OutperformMarket Outperform||Maintains||-||12.00|
|Ticker||Company||Chg %||Mkt Cap|
You can purchase shares of BioAtla (NASDAQ: BCAB) through any online brokerage.
The latest price target for BioAtla (NASDAQ: BCAB) was reported by HC Wainwright & Co. on Wednesday, November 8, 2023. The analyst firm set a price target for 10.00 expecting BCAB to rise to within 12 months (a possible 464.97% upside). 17 analyst firms have reported ratings in the last year.
The stock price for BioAtla (NASDAQ: BCAB) is $1.77 last updated Today at November 30, 2023 at 9:20 PM UTC.
There is no dividend information for BioAtla.
BioAtla’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for BioAtla.
BioAtla is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.